<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="319761" id="root" date="1997-01-20" xml:lang="en">
<title>SWITZERLAND: Novartis names Yetter U.S. pharma ceo.</title>
<headline>Novartis names Yetter U.S. pharma ceo.</headline>
<dateline>BASLE, Switzerland 1997-01-20</dateline>
<text>
<p>Swiss pharmaceuticals giant Novartis said it named Wayne Yetter president and chief executive of Novartis Pharmaceuticals Corp USA, effective February 1.</p>
<p>Yetter has held the positions of general manager and then president of Astra Merck Inc since 1991. He joined Merck and Co in 1977 and held several marketing positions before becoming vice president for the Far East/Pacific region.</p>
<p>He has also spent seven years at Pfizer in sales and marketing in the U.S.</p>
<p>The Novartis healthcare business in the U.S. has an estimated $4.0 billion in sales for 1996 on a pro-forma basis, Novartis said in a statement.</p>
<p>It said the U.S. represents about one-third of its worldwide business with estimated pro-forma sales for 1996 of nearly $8.0 billion.</p>
<p>Prescription pharmaceutical activities in the U.S. include therapeutic franchises in transplantation/ immunology, cardiovascular, central nervous system disorders, oncology, arthritis/inflammation and dermatology.</p>
<p>Key products in the U.S. include the trademarked products Lescol, Lotensin, Lamisil and Miacalcin nasal spray.</p>
<p>Other products include Diovan, an Antiotensin II antagonist for hypertension approved by Food and Drug Administration in December 1996, and Aredia for osteolytic bone metastases of breast cancer.</p>
<p>Apligra, for wound healing, is currently being reviewed by the FDA.</p>
<p>-- Zurich Editorial +41 1 631 7340</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="SWITZ">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-20"/>
  </code>
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-20"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-20"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C41">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-20"/>
  </code>
  <code code="C411">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-20"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-20"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-01-20"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-01-20"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="BASLE, Switzerland"/>
<dc element="dc.creator.location.country.name" value="SWITZERLAND"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
